Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19880109 | 0.96 | POLB (0.32) | POLBEPHX1 | |
| SCHEMBL410831 | 0.87 | TSHR (0.39) | TSHRTDP1 | |
| SCHEMBL3431415 | 0.86 | POLB (0.31) | POLB | |
| SCHEMBL15759764 | 0.85 | LMNA (0.30) | — | |
| SCHEMBL11173896 | 0.85 | CYP2D6 (0.33) | — | |
| SCHEMBL12694198 | 0.85 | — | — | |
| Thiocyanic Acid SCHEMBL11817268 | 0.83 | DPP4 (0.33) | — | |
| SCHEMBL23734233 | 0.81 | — | — | |
| SCHEMBL16541994 | 0.81 | — | — | |
| SCHEMBL24008436 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9226925-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2016-01-05 | — | — | US | claimed |
| US-8940729-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2015-01-27 | — | — | US | claimed |
| US-8912217-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2014-12-16 | — | — | US | claimed |
| US-20080090742-A1 | Compound and method of making the compound | AFTON CHEMICAL CORPORATION | 2008-04-17 | — | — | US | claimed |
| CN-119677819-A | Azo compound or salt thereof, and polarizing film, polarizing plate and liquid crystal display device each containing the same | 日本化药株式会社 | 2025-03-21 | — | — | CN | disclosed |
| US-20240262850-A1 | PHOSPHITE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-08-08 | — | — | US | disclosed |
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-05-23 | — | — | US | disclosed |
| EP-4349920-A1 | PHOSPHITE ESTER COMPOSITION | Sumitomo Chemical Company Limited (JP) | 2024-04-10 | — | — | EP | disclosed |
| EP-4317166-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME, AND USE APPLICATION FOR SAME | Sumitomo Chemical Company Limited (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-117413025-A | Phosphite compositions | 住友化学株式会社 | 2024-01-16 | — | — | CN | disclosed |
| CN-114026199-B | Polarized light emitting film, polarized light emitting panel and display device containing water-soluble coumarin compound or salt thereof | 日本化药株式会社 | 2023-12-26 | — | — | CN | disclosed |
| CN-117120454-A | Phosphite compound, process for producing the same, and use thereof | 住友化学株式会社 | 2023-11-24 | — | — | CN | disclosed |
| EP-0861847-A2 | Stabilizer composition and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-09-02 | — | — | EP | disclosed |
| EP-0827953-A2 | Method for producing N-acyl carbamate | Nippon Paint Co., Ltd. (JP) | 1998-03-11 | — | — | EP | disclosed |
| EP-0823435-A2 | Phosphites, process for producing the same and their use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-02-11 | — | — | EP | disclosed |
| EP-0763555-A2 | Alkylene oxide polymerisation catalysts | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1997-03-19 | — | — | EP | disclosed |
| US-5576365-A | HEAT AND OXIDATION RESISTANCE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-11-19 | — | — | US | disclosed |
| EP-0684279-A1 | A phosphorus type stabilizer and an organic material stabilized by the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-11-29 | — | — | EP | disclosed |
| US-5328619-A | Inhibiting haze in a concentrate of boronated ashless dispersant and acidic additive by adding an amine to control the pH to 6-7; storage stability; extreme pressure lubricants; auto gears | ETHYL PETROLEUM ADDITIVES, INC. (US) | 1994-07-12 | — | — | US | disclosed |
| EP-0519760-A1 | Oil additive concentrates and lubricants of enhanced performance capabilities | ETHYL PETROLEUM ADDITIVES, INC. (US) | 1992-12-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | EBPL, ACSL6, ACSL3 | POLB 3722/4885EPHX1 1031/4885TSHR 4622/4885 |
| US-20240262850-A1 | PHOSPHITE COMPOSITION | PHOSPHO1, PLCG2, PPA1 | POLB 2393/4885EPHX1 2088/4885TSHR 4260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.